• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) ORBERA INTRAGASTRIC BALLOON; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) ORBERA INTRAGASTRIC BALLOON; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Catalog Number B-50000
Device Problems Fluid/Blood Leak (1250); Inflation Problem (1310); Out-Of-Box Failure (2311)
Patient Problem Failure of Implant (1924)
Event Date 10/24/2015
Event Type  malfunction  
Manufacturer Narrative
The reporter of the complaint was asked to return the product for analysis.The device has not yet been received by allergan.Allergan has not received the product at this time.Therefore no analysis or testing has been done.Device labeling addresses the possible outcome of an insufficiently inflated or leaking device as follows: possible complications of the use of the orbera¿ system include: intestinal obstruction by the balloon.An insufficiently inflated balloon or a leaking balloon that has lost sufficient volume may be able to pass from the stomach into the small bowel.It may pass all the way through into the colon and be passed with stool.However, if there should be a narrow area in the bowel, as might occur after prior surgery on the bowel and adhesion formation, the balloon may not pass and then may cause a bowel obstruction.If this occurs, percutaneous drainage, surgery, or endoscopic removal could be required.Device labeling addresses the reported event of "dysmorphic" as follows: the orbera¿ system balloon is placed in the stomach and filled with saline, causing it to expand into a spherical shape (fig 2).
 
Event Description
Physician reported, "balloon did not expanded correctly during insufflation, was dysmorphic." also physician reported device was "leaking the solution with methylene blue." device was removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON
Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS  
Manufacturer Contact
laura leboeuf
1120 s capital of texas hwy
building 1, suite 300
austin, TX 78748
8555513123
MDR Report Key5229550
MDR Text Key31377149
Report Number3006722112-2015-00557
Device Sequence Number1
Product Code LTI
UDI-Device Identifier10811955020541
UDI-Public(01)10811955020541(10)2705250(11)150213(17)170213
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/17/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/13/2017
Device Catalogue NumberB-50000
Device Lot Number2705250
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/26/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/13/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age43 YR
Patient Weight95
-
-